Product Information
IMIPRAMINE PAMOATE 100 MG CAP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $3.5165 per EA under NDC 00054027413. Its NADAC has been published 518 times since Nov 28, 2013.
FDA first approved this application on Apr 16, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054027413
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMIPRAMINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA091099FDA Approved
4/16/2010
TE Code
AB
On Market Since
4/19/2010
Pharmacological Classes
Price Statistics
The NADAC for IMIPRAMINE PAMOATE 100 MG CAP has been published 518 times since Nov 28, 2013, and over the history we have for it it has declined 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5165 per EA |
|---|---|
| All-time high | $8.9948 (Jun 15, 2016) |
| All-time low | $3.2982 (Apr 22, 2026) |
| 52-week high | $3.6892 |
| 52-week low | $3.2982 |
| Median price | $5.7455 |
| Average price | $5.8159 |
| Largest weekly change | +44.9% (Jan 22, 2014) |
| Weeks tracked | 518 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMIPRAMINE PAMOATE 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE PAMOATE 100 MG CAP, manufactured by Hikma Pharmaceuticals USA Inc., is $3.5165 per EA (NDC 00054027413), effective Aug 19, 2026.
How has the price of IMIPRAMINE PAMOATE 100 MG CAP changed over time?
Over the history we have for it, the NADAC for IMIPRAMINE PAMOATE 100 MG CAP has declined 39.8%. It has been tracked across 518 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMIPRAMINE PAMOATE 100 MG CAP?
Since Nov 28, 2013, the NADAC for IMIPRAMINE PAMOATE 100 MG CAP has ranged from a low of $3.2982 (Apr 22, 2026) to a high of $8.9948 (Jun 15, 2016), with a median of $5.7455 per EA.
Are there cheaper alternatives to IMIPRAMINE PAMOATE 100 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IMIPRAMINE PAMOATE 100 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures IMIPRAMINE PAMOATE 100 MG CAP?
IMIPRAMINE PAMOATE 100 MG CAP (NDC 00054027413) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.